Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.37B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$488M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$449M |
| 4 |
Apple
AAPL
|
+$402M |
| 5 |
HES
Hess
HES
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.47B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$1.44B |
| 3 |
NVIDIA
NVDA
|
+$783M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$722M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$650M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.34% |
| 2 | Healthcare | 6.09% |
| 3 | Financials | 5% |
| 4 | Consumer Discretionary | 4.53% |
| 5 | Industrials | 4.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4451
PUT
Corcept Therapeutics
CORT
$12.4B
| $578K | ﹤0.01% |
17,800
-99,600
| -85% | -$2.73M |
|
|
ACH
4452
CALL
Accendra Health
ACH
$237M
| $578K | ﹤0.01% |
30,000
+9,200
| +44% | +$167K |
|
4453
TScan Therapeutics
TCRX
$48.6M
| $578K | ﹤0.01% |
+99,082
| New | +$454K |
|
|
ARIS
4454
DELISTED
Aris Water Solutions
ARIS
| $577K | ﹤0.01% |
68,768
-98,626
| -59% | -$848K |
|
4455
Cardlytics
CDLX
$21.7M
| $577K | ﹤0.01% |
+6,260
| New | +$636K |
|
4456
iShares MSCI Turkey ETF
TUR
$200M
| $576K | ﹤0.01% |
17,849
-68,150
| -79% | -$2.41M |
|
4457
Compañía de Minas Buenaventura
BVN
$7.69B
| $576K | ﹤0.01% |
37,791
+2,756
| +8% | +$26.6K |
|
4458
PUT
Myriad Genetics
MYGN
$270M
| $574K | ﹤0.01% |
+30,000
| New | +$519K |
|
4459
CALL
Zebra Technologies
ZBRA
$14B
| $574K | ﹤0.01% |
+2,100
| New | +$479K |
|
4460
Vericel Corp
VCEL
$2.35B
| $572K | ﹤0.01% |
16,072
-15,720
| -49% | -$547K |
|
4461
inTEST
INTT
$155M
| $571K | ﹤0.01% |
41,998
+29,796
| +244% | +$395K |
|
4462
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.62B
| $568K | ﹤0.01% |
+14,487
| New | +$520K |
|
4463
CALL
LeMaitre Vascular
LMAT
$2.32B
| $568K | ﹤0.01% |
+10,000
| New | +$524K |
|
4464
Veracyte
VCYT
$3.7B
| $567K | ﹤0.01% |
20,628
-28,322
| -58% | -$684K |
|
4465
XPEL
XPEL
$1.22B
| $567K | ﹤0.01% |
10,527
+4,081
| +63% | +$219K |
|
4466
Stem
STEM
$48.4M
| $564K | ﹤0.01% |
7,264
+1,360
| +23% | +$93.8K |
|
|
DFP
4467
Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP
$427M
| $561K | ﹤0.01% |
31,628
-5,704
| -15% | -$96.1K |
|
4468
CALL
Starwood Property Trust
STWD
$5.92B
| $561K | ﹤0.01% |
26,700
-26,700
| -50% | -$524K |
|
4469
CALL
Tredegar Corp
TG
$265M
| $561K | ﹤0.01% |
+103,700
| New | +$511K |
|
4470
Personalis
PSNL
$1.35B
| $560K | ﹤0.01% |
266,897
+152,003
| +132% | +$196K |
|
4471
Investar Holding Corp
ISTR
$415M
| $560K | ﹤0.01% |
37,584
-5,503
| -13% | -$62.6K |
|
4472
CALL
SIGA Technologies
SIGA
$235M
| $560K | ﹤0.01% |
+100,000
| New | +$536K |
|
4473
PUT
10x Genomics
TXG
$6B
| $560K | ﹤0.01% |
+10,000
| New | +$435K |
|
4474
Shake Shack
SHAK
$2.53B
| $559K | ﹤0.01% |
7,540
-154,636
| -95% | -$9.48M |
|
4475
Genco Shipping & Trading
GNK
$1.11B
| $557K | ﹤0.01% |
33,576
+9,972
| +42% | +$145K |
|
Similar funds
Millennium Management's Q4 2023 Portfolio in Review
As of Q4 2023, Millennium Management held 6,891 positions worth $231B, up 17% from $198B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Millennium Management deployed $7.99B of net new capital in Q4 2023, opening 816 new positions and adding to 2,304 existing holdings. Its largest new stake was Ferguson: 906,589 shares worth $175M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 9.2% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.47B trimmed.
- Millennium Management's largest Q4 2023 buy was Ferguson: 906,589 shares worth $175M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $4.37B increase.
- Millennium Management's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.47B.
- Millennium Management fully exited Activision Blizzard in Q4 2023, selling an estimated $1.44B.
- Millennium Management's ten largest holdings make up 21% of its $231B portfolio in Q4 2023.
- Millennium Management opened 816 new positions and closed 883 in Q4 2023.
- Millennium Management's portfolio value rose 17% quarter-over-quarter to $231B.
Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.